EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nuclear-Magnetic-Resonance-Spectroscopy-Derived Serum Biomarkers of Metabolic Vulnerability Are Associated with Disability and Neurodegeneration in Multiple Sclerosis

Taylor R Wicks iD, Irina Shalaurova, Richard W Browne, Anna Wolska iD, Bianca Weinstock-Guttman iD, Robert Zivadinov, Alan T Remaley, James D Otvos, Murali Ramanathan

Nutrients · 2024

DOI: 10.3390/nu16172866 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Taylor R Wicks und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, State University of New York, Buffalo, NY 14214, USA. Hauptthemen laut MEDLINE: Biomarkers. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Defense Congressionally Directed Medical Research Programs, USAMRDC, Multiple Sclerosis Research Programs, Department of Defense Congressionally Directed Medical Research Programs, USAMRDC, Multiple Sclerosis Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Metabolic vulnerabilities can exacerbate inflammatory injury and inhibit repair in multiple sclerosis (MS). The purpose was to evaluate whether blood biomarkers of inflammatory and metabolic vulnerability are associated with MS disability and neurodegeneration.

Methods

Proton nuclear magnetic resonance spectra were obtained from serum samples from 153 healthy controls, 187 relapsing–remitting, and 91 progressive MS patients. The spectra were analyzed to obtain concentrations of lipoprotein sub-classes, glycated acute-phase proteins, and small-molecule metabolites, including leucine, valine, isoleucine, alanine, and citrate. Composite indices for inflammatory vulnerability, metabolic malnutrition, and metabolic vulnerability were computed. MS disability was measured on the Expanded Disability Status Scale. MRI measures of lesions and whole-brain and tissue-specific volumes were acquired.

Results

Valine, leucine, isoleucine, alanine, the Inflammatory Vulnerability Index, the Metabolic Malnutrition Index, and the Metabolic Vulnerability Index differed between healthy control and MS groups in regression analyses adjusted for age, sex, and body mass index. The Expanded Disability Status Scale was associated with small HDL particle levels, inflammatory vulnerability, and metabolic vulnerability. Timed ambulation was associated with inflammatory vulnerability and metabolic vulnerability. Greater metabolic vulnerability and inflammatory vulnerability were associated with lower gray matter, deep gray matter volumes, and greater lateral ventricle volume.

Conclusions

Serum-biomarker-derived indices of inflammatory and metabolic vulnerability are associated with disability and neurodegeneration in MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersHumansFemaleMaleMiddle AgedAdultMagnetic Resonance ImagingMultiple SclerosisMultiple Sclerosis, Relapsing-RemittingCase-Control StudiesMagnetic Resonance SpectroscopyInflammationGray MatterMultiple Sclerosis, Chronic ProgressiveDisability EvaluationBrain

Stichwörter der Autor:innen

branched-chain amino acidscholesterollipoproteinsmetabolic vulnerabilitynuclear magnetic resonance

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, State University of New York, Buffalo, NY 14214, USA.
  • LabCorp Diagnostics, Morrisville, NC 27560, USA.
  • Biotechnical and Clinical Laboratory Sciences, State University of New York, Buffalo, NY 14214, USA.
  • Lipoprotein Metabolism Laboratory, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Department of Neurology, State University of New York, Buffalo, NY 14203, USA.

ORCID-Profile: Taylor R Wicks, Anna Wolska, Bianca Weinstock-Guttman

Förderung

  • Department of Defense Congressionally Directed Medical Research Programs, USAMRDC, Multiple Sclerosis Research Programs
  • Department of Defense Congressionally Directed Medical Research Programs, USAMRDC, Multiple Sclerosis Research Program

Zitieren

APA

Wicks, T. R., Shalaurova, I., Browne, R. W., Wolska, A., Weinstock-Guttman, B., Zivadinov, R., Remaley, A. T., Otvos, J. D., & Ramanathan, M. (2024). Nuclear-Magnetic-Resonance-Spectroscopy-Derived Serum Biomarkers of Metabolic Vulnerability Are Associated with Disability and Neurodegeneration in Multiple Sclerosis. Nutrients. https://doi.org/10.3390/nu16172866

Vancouver

Wicks TR, Shalaurova I, Browne RW, Wolska A, Weinstock-Guttman B, Zivadinov R, et al. Nuclear-Magnetic-Resonance-Spectroscopy-Derived Serum Biomarkers of Metabolic Vulnerability Are Associated with Disability and Neurodegeneration in Multiple Sclerosis. Nutrients. 2024. doi:10.3390/nu16172866

BibTeX
@article{Wicks2024,
  author = {Wicks, Taylor R and Shalaurova, Irina and Browne, Richard W and Wolska, Anna and Weinstock-Guttman, Bianca and Zivadinov, Robert and Remaley, Alan T and Otvos, James D and Ramanathan, Murali},
  title = {Nuclear-Magnetic-Resonance-Spectroscopy-Derived Serum Biomarkers of Metabolic Vulnerability Are Associated with Disability and Neurodegeneration in Multiple Sclerosis},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16172866}
}
Kostenlos starten →